Cargando…
Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382480/ https://www.ncbi.nlm.nih.gov/pubmed/34133358 http://dx.doi.org/10.1097/CM9.0000000000001522 |
| _version_ | 1783741542119243776 |
|---|---|
| author | Ma, Li Ge, Zhi-Cheng Xin, Ling Wang, Ying-Xin Zhang, Yan-Shou Tang, Tian-Tian Gao, Guo-Xuan Liu, Qian Zhao, Xuan Liu, Yun-Jiang Qu, Xiang |
| author_facet | Ma, Li Ge, Zhi-Cheng Xin, Ling Wang, Ying-Xin Zhang, Yan-Shou Tang, Tian-Tian Gao, Guo-Xuan Liu, Qian Zhao, Xuan Liu, Yun-Jiang Qu, Xiang |
| author_sort | Ma, Li |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8382480 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83824802021-09-01 Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 Ma, Li Ge, Zhi-Cheng Xin, Ling Wang, Ying-Xin Zhang, Yan-Shou Tang, Tian-Tian Gao, Guo-Xuan Liu, Qian Zhao, Xuan Liu, Yun-Jiang Qu, Xiang Chin Med J (Engl) Consensus Statements Lippincott Williams & Wilkins 2021-08-20 2021-06-16 /pmc/articles/PMC8382480/ /pubmed/34133358 http://dx.doi.org/10.1097/CM9.0000000000001522 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivitives 3.0 License, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially. http://creativecommons.org/licenses/by-nc-nd/3.0 (https://creativecommons.org/licenses/by-nc-nd/3.0/) |
| spellingShingle | Consensus Statements Ma, Li Ge, Zhi-Cheng Xin, Ling Wang, Ying-Xin Zhang, Yan-Shou Tang, Tian-Tian Gao, Guo-Xuan Liu, Qian Zhao, Xuan Liu, Yun-Jiang Qu, Xiang Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 |
| title | Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 |
| title_full | Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 |
| title_fullStr | Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 |
| title_full_unstemmed | Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 |
| title_short | Clinical practice guidelines for breast cancer implantable intravenous infusion ports: Chinese Society of Breast Surgery practice guidelines 2021 |
| title_sort | clinical practice guidelines for breast cancer implantable intravenous infusion ports: chinese society of breast surgery practice guidelines 2021 |
| topic | Consensus Statements |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8382480/ https://www.ncbi.nlm.nih.gov/pubmed/34133358 http://dx.doi.org/10.1097/CM9.0000000000001522 |
| work_keys_str_mv | AT mali clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT gezhicheng clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT xinling clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT wangyingxin clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT zhangyanshou clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT tangtiantian clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT gaoguoxuan clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT liuqian clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT zhaoxuan clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT liuyunjiang clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 AT quxiang clinicalpracticeguidelinesforbreastcancerimplantableintravenousinfusionportschinesesocietyofbreastsurgerypracticeguidelines2021 |